MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK)
Organization & Developments: Merrimack
Parents
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK)
Children
2016: Merrimack: Restructuring And Onivyde Growth To Yield Results - Merrimack Pharmaceuticals (NASDAQ:MACK)
2017: Biotech Forum Daily Digest: Biotech Continues To Rally; Revisiting Merrimack Pharmaceuticals After Monday's Events - Merrimack Pharmaceuticals (NASDAQ:MACK)
2017: Investors Don't Like The 'New Merrimack' - Merrimack Pharmaceuticals (NASDAQ:MACK)
2017: Merrimack Hits Reset Button, Sells Cancer Drugs to Ipsen For $575M
2018: Merrimack Fails Phase 2 Pancreatic Cancer Study, But Opportunity Remains_seekingalpha.com
The money will go to advancing Merrimack’s pipeline of novel cancer therapies.
Jumps
*Key People: Merrimack
Finance & Acquisitions: Merrimack